Preliminary results of neoadjuvant chemotherapy in resectable gastric cancer
Neoadjuvant chemotherapy (NAC) for resectable gastric cancer (GC) has demonstrated benefits in survival rates in key studies. The safety and risks of neoadjuvant chemotherapy (NAC) remain a matter of debate. Objective. Evaluate the immediate results of chemotherapy in resectable gastric cancer. Material and methods. Th...